The Laboratory Report
Fall 2020
Welcome to the Fall 2020 Houston Methodist Hospital Department of Pathology and Genomic Medicine Newsletter: The Laboratory Report. If you have contributions or feedback for upcoming newsletters, please email us.
In this issue:
  1. Faculty Accomplishments
  2. Updates from the Community
  3. Laboratory News
  4. Trainee News
  5. New Faculty
  6. Faculty Appointments & Promotions
  7. Office of Academic Development News
  8. Departmental Publications
Faculty Accomplishments
Dr. Bertholf Earns ASCP Mastership Award
Roger L. Bertholf, PhD, was awarded Mastership designation by the American Society for Clinical Pathology (ASCP) at their 2020 Virtual Annual Meeting this September. ASCP Mastership is an elite designation that recognizes ASCP members who have made “a significant contribution to pathology through sustained service to the profession and to the Society.”

Dr. Bertholf joined our Department in 2017. He serves as Medical Director of Clinical Chemistry for HMH, is the Program Director of our Clinical Chemistry Fellowship, and is a Professor of Clinical Pathology and Genomic Medicine at the Houston Methodist Academic Institute (HMAI) and Professor of Clinical Pathology and Laboratory Medicine at Weill Cornell Medical College (WCMC).

Amongst his many contributions to the ASCP, Dr. Bertholf has served since 2012 as the editor-in-chief of the ASCP’s journal, Laboratory Medicine. Of his Mastership designation, Dr. Bertholf said: “I have been involved with the ASCP for nearly my entire career, beginning with my first Workshop for Laboratory Professionals in 1993. When I was selected in 2012 as editor of Laboratory Medicine, one of the two scientific journals published by the ASCP, it provided me with an opportunity to make a substantive contribution to the society’s reputation for promoting scholarly activity. Their recognition of my contributions with the ASCP Mastership Award is among the most professionally and personally gratifying honors I have received.”
 
Congratulations, Dr. Bertholf!
Dr. Cykowski Receives Career-First NIH Grant
and Career Cornerstone Recognition
Matthew Cykowski, MD, Assistant Professor of Pathology and Genomic Medicine, Assistant Professor of Neurology, and Director of Autopsy, recently received an R01-equivalent NIH award from the National Institute of Neurological Disorders and Stroke (NINDS). The project is titled: "Age-related TDP-43 neuropathology: using disease-driving mechanisms to guide classification" (1 RF1 NS118584-01, 06/2020-05/2025). Dr. Cykowski's application was in response to a September 2019 RFA by the NINDS and National Institute on Aging to investigate mechanisms of TDP-43 pathobiology in common dementias. Dr. Cykowski, along with co-PI Peter Nelson, MD, at the University of Kentucky and a team of scientists at both HMH and the University of Kentucky, will investigate the pathologic and genetic basis of limbic-predominant age-related TDP-43 encephalopathy (LATE), one of the most common pathologic substrates of dementia in older individuals.

In recognition of this first R01-equivalent grant, Dr. Cykowski was the recipient of the Houston Methodist Academic Institute (HMAI) President’s Career Cornerstone Award. The award provides discretionary funding to allow first-time PIs to pursue academic activities, and is active for the duration of the associated NIH grant. Dr. Cykowski was recognized at the October 29th HMAI Town Hall meeting.

Congratulations, Dr. Cykowski!
Dr. Salazar Recognized by NBC News as “Latino Hospital Hero”
Eric Salazar, MD, PhD, was recognized by NBC News in a September feature as a “Latino Hospital Hero.” The piece spotlighted Dr. Salazar’s early life in rural South Texas, his educational background, and the work he is currently performing at the forefront of SARS-CoV-2 pandemic research in the form of convalescent plasma treatment for severely ill COVID-19 patients. In the article, Dr. Salazar credits his parents and their work ethic for his successful career. The article quotes a 2018 study by the Association of American Medical Colleges that less than 6% of all active physicians are of Latinx heritage, putting Dr. Salazar in an elite group of medical professionals

Dr. Salazar currently serves as Co-Medical Director of Transfusion Medicine and Medical Director of Coagulation Laboratories at HMH, and he is an Assistant Professor of Pathology and Genomic Medicine at the HMAI and Assistant Professor Pathology and Laboratory Medicine at WCMC. Dr. Salazar’s research in the area of convalescent plasma therapy has been featured in numerous journals, including an article in The American Journal of Pathology that represented the first media unicorn (>1 billion unique views) for Houston Methodist Hospital.

Congratulations, Dr. Salazar!
Meeting with Surgeon General
Surgeon General of the United States, Vice Admiral Dr. Jerome M. Adams, met in early October with HMH CEO Dr. Marc Boom, Department members Dr. James M. Musser and Dr. Eric Salazar, Dr. Faisal Masud, and others to discuss convalescent plasma therapy and COVID-19.
Departmental Media Appearances
S. Wesley Long, MD, PhD, was featured in articles for Healthline and The Healthy on COVID-19 super spreader events.

- - -

Katherine Perez, PharmD, BCPS-AQ ID, was interviewed by Reuters on the availability and use of remdesivir as a COVID-19 treatment.

- - -

James M. Musser, MD, PhD, was interviewed for a Washington Post exclusive on an mBio article authored by Dr. Musser and his team on mutations in the second wave of the SARS-CoV-2 virus in Houston.
Updates from the Community
Hurricane season is almost over! We are incredibly proud of how everyone, especially our laboratory staff, has responded and prepared as Hurricane Laura threatened our community. Hurricane Laura was expected to make landfall as a Category 4 hurricane near Sabine Pass, approximately 80 miles east of our hospital. We prepared for potentially significant sustained winds and rain that could cause downed power lines and debris in the roads, making safe commuting an issue. In order to maintain social distancing and keep employees safe, some of the private offices were utilized as resting rooms by our great laboratory ride-out team. We were fortunate that Hurricane Laura had very little impact on our area, but we remain alert for potential future storms and actively work on hospital-wide and laboratory-specific contingency plans. Although Tropical Storm Beta threatened us with heavy rain, HMB remained open.

Houston Methodist Baytown earns 4-star rating! Thanks to an amazing group effort and outstanding leadership, HMB moved significantly in ranking and earned a 4-star safety rating from Vizient. The noticeable improvement in all parameters exemplifies the deep commitment toward our patients’ safety. Next milestone: 5 stars!
Laboratory construction project underway at HMB.
Constant growth and development continue at Baytown! Part of the facility master plan includes the new patient parking canopy, part of the parking deck project located between the main hospital building and the OPC, and construction of the five-story med/surg tower (depicted above). On September 14, construction in the laboratory began with Phase 1. This phase includes construction and the relocation of processing, storage, and offices. There will be five phases in total, with Histology being the last part to be built (completion anticipated by April 2023).
From David Alrahwan, MD, Medical Director,
Houston Methodist Clear Lake Hospital (HMCL)
The HMCL Laboratory performed a College of American Pathologists (CAP) educational inspection of LabCorp Houston on October 2. Our laboratory was inspected by CAP on November 2.
 
Barcode scanning for positive patient identification (PPID) will go live at HMCL on December 8. We are excited to introduce another practice to ensure patient safety in our lab.
 
HMCL is obtaining a new emergency care center (ECC) in Deer Park. The Deer Park ECC will have on-site laboratory services which will go live in December.
From Seema Mullick, MD, Medical Director,
Houston Methodist Sugar Land Hospital (HMSL)
HMSL is happy to report that our anatomic and clinical volumes are almost back to normal!
From Hazel Awalt, MD, Medical Director,
Houston Methodist The Woodlands Hospital (HMTW)
HMTW is pleased to report that we underwent a successful CAP inspection on October 5, under the leadership of Dr. Ruba Halloush!
From Byron Moore, MD, Medical Director,
Houston Methodist Willowbrook Hospital (HMWB)
Houston Methodist Willowbrook Pathology Department is looking forward to an expansion of the Anatomic Pathology area. Two more grossing bays will be added to the two existing grossing bays, for a total of four, which will aid in creating a safer and more efficient work flow. We anticipate construction beginning around the New Year.

We have transitioned to using two blood types in order to issue ABO compatible blood. Previously, HMWB used a blood band system, so we are excited to have less patient identification issues while still providing safe blood for our patients.

We have welcomed new Chief Techs for day shift and evening shift: welcome Nora Somuyiwa and Buena Umali!

Lastly, our new Sysmex DI-60 cell imaging analyzer is now active for use on patient specimens (automated CBC analysis with cell imaging).
Laboratory News
HMH Cytology Team Participates in CAP
 "See, Test, and Treat" Event
Members of the HMH cytology staff took part in the October 17 Liberty/Dayton “See, Test, and Treat” event sponsored by the College of American Pathologists (CAP). Because of COVID-19, the event took place differently than in previous years. All specimens were collected, batched, and sent to the lab at the end of the event. In the interest of social distancing, same-day results were not available; however, all cervical pap smears collected at the event were processed the same day and results were made available in the following days.

Top row (left to right): Denise Russel-Burn, Eric Luna, Rhea Enifo, Melissa Jimenez, Debora Smith, Monica Green, Ivonne Vega, Justus Awolu

Bottom row (left to right): Krystal Robinson, Heather Blailock, Cynthia Renteria, Dr. Dina Mody, Nancy Beltran, Donna Armylagos
CAP “See, Test, and Treat” events provide culturally and linguistically-appropriate cervical and breast cancer screenings to underserved women who might otherwise be unable to access these services. This year’s event provided cervical cancer screenings for 36 women, including two for whom further referrals were made.

Department members who volunteered at the event included: Donna Armylagos, Justus Awolu, Nancy Beltran, Brittany DiPietro, Rhea Enifo, Monica Green, Melissa Jimenez, Cynthia Renteria, Krystal Robinson, Stephanie Simon, Debora Smith, Ivonne Vega, Eric Luna, and Dr. Dina Mody.
HLA Lab Earns ASHI Accreditation
Todd Eagar, PhD, Associate Medical Director of Histocompatibility and Immunogenetics Laboratory, reports that the Laboratory recently was granted approval by the American Society for Histocompatibility and Immunogenetics (ASHI) for the use of Next Generation Sequencing (NGS). NGS has become a mainstay of molecular testing and Human Leukocyte Antigen (HLA) HLA typing. The laboratory applied for accreditation to use NGS-based HLA typing. For their validation studies, lab members typed over 100 samples, including 20 unknown samples, with 100% concordance observed with prior typing results.
 
HLA typing is performed using a combination of three molecular methods: sequence-specific oligonucleotide probes (SSO), Sanger’s sequencing based typing (SBT), and sequence-specific priming. There are two primary benefits for NGS typing. First, NGS-based typing improves transplant outcomes by providing high-resolution HLA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5, DQA1, DQB1, DPA1, and DPB1. This benefits transplant patients by allowing clinical teams to identify better matched donors. High resolution typing of donors will also allow the laboratory to better assess immune responses against the donor. Second, NGS increases the efficiency of HLA typing by moving tests to a single platform and by improving the automation of sequence analysis.  

ASHI accreditation for NGS testing is the culmination of much hard work on the part of the HLA team. Congratulations to Dr. Eagar, Dr. Nicholas DiPaoloa, Dr. Michael Greenwood, and all of the staff who made this accomplishment possible!
Department Members Participate
in International Educational Outreach
Dr. Ziad El-Zaatari, Monica Lemos, and Dr. Ekene Okoye with the "Atlas of Surgical Pathology Grossing."
Pathology Assistant Monica Lemos, with Surgical Pathology Fellow Ziad El-Zaatari, MD, created and presented an educational lecture via videoconferencing on the challenges of grossing gynecological specimens to a group of pathologists in Mozambique, Africa. The presentation, based on Ms. Lemos’ highly-successful “Atlas of Surgical Pathology Grossing,” gave attendees a wealth of practical tips and knowledge for performing grossing in low-resource settings, and was part of the inaugural session of Project ECHO (Extension for Community Healthcare Outcomes) in Portuguese-speaking regions of Africa.
Spearheaded by Dr. Marcia Edelweiss of Memorial Sloan Kettering Cancer Center, Project ECHO’s Lusophone Africa project provides local healthcare professionals in isolated or research-constrained areas of Portuguese-speaking Africa with the opportunity to interact with colleagues from the United States and around the world to enhance knowledge and learn valuable diagnostic strategies.

Many thanks to Ms. Lemos and Dr. El-Zaatari for their commitment to global pathology education!
Department Members Volunteer
for COVID-19 Vaccine Trials
Departmental members S. Wesley Long, MD, PhD, Adrienne Winston, and Sasha M. Pejerrey, PhD, have signed up to be part of the COVID-19 vaccine trial volunteer network for COVID-19 vaccine Phase 3 clinical trials. All three volunteers are in the selection phase for the trials and await selection or enrollment by various vaccine development companies, including Moderna, Pfizer, Astra-Zeneca, and NovaVax.

In addition to his tireless work fighting COVID-19 in the laboratory, Dr. Long has historically been a vaccine advocate: “I’m a big vaccine proponent. I had a one-year vaccine development fellowship in grad school, and have always spoken out in support of vaccines. Everyone knows someone–a family member, neighbor, colleague—who needs protecting by a vaccinated populace.” Dr. Long has been selected for screening by three vaccine trials.

Ms. Winston commented, as she awaits her appointment with Moderna, “I am proud to have the opportunity to effect scientific progress for the good and to potentially assist in a small way in ending the COVID-19 crisis. Vaccines are safe, effective, and necessary for us to be able to live in the public space; in volunteering for these trials I feel that I am really standing behind my trust in them.”

“I am excited at the possibility to walk the walk for science, vaccines, and a safe way out of the COVID-19 crisis,” said Dr. Pejerrey, who has begun the screening process for Moderna.

If you are interested in volunteering as a COVID-19 vaccine clinical trial participant, please visit https://www.coronaviruspreventionnetwork.org/.

Trainee News
Trainee Redeployment Manuscript Published
in Academic Pathology
Residents and fellows in our Department’s 2019-20 cohort of trainees, as well as faculty from specialties in both Anatomic and Clinical Pathology,are thrilled to announce the publication of their article “Pathology Trainee Redeployment and Education during the COVID-19 Pandemic: An Institutional Experience” in the September issue of Academic Pathology.

The article was born from the experience of our Department’s trainees and faculty re-entering the laboratories during the first wave of the current COVID-19 pandemic. Jessica Thomas, MD, PhD, Associate Medical Director of the Molecular Pathology Diagnostic Laboratory, Program Director of the Molecular Genetic Pathology Fellowship, Associate Program Director for Clinical Pathology in the Pathology Residency Program, Assistant Professor of Clinical Pathology at the HMAI and Weill Cornell, and corresponding author of the article, said that at the beginning of the COVID-19 pandemic, “many AP service lines saw overall decreased case volumes, while the clinical pathology laboratories had multiple efforts in support of Houston Methodist’s COVID19 response. The Department’s trainee redeployment was an opportunity for our Pathology residents and fellows to be involved in our response to COVID-19. They became involved in a number of activities and projects, including COVID-19-related assay development and validations, the convalescent plasma trial, and informatics and research projects, just to name a few. The COVID-19 virtual seminar series allowed trainees to both learn from each other and share their experiences during redeployment. It was wonderful working closely with the trainees and providing such a valuable educational experience for them during a difficult time.”

Suzanne Z. Powell, MD, Vice-Chair for Education, Chief of Neuropathology, Director of the Pathology Residency Program and Neuropathology Fellowship Program, Professor of Pathology at the HMAI and Weill Cornell, and author in the article said, “As the first wave of the COVID-19 pandemic occurred, the Department divided our residents and fellows into two groups, with one working from home and the other in the hospital. Originally planned for exchange after two weeks, the second two-week period began as planned, but quickly escalated to not only bringing all trainees back to the hospital, but with a redeployment plan of trainees to support the COVID-19 response. The case volumes in anatomic pathology had plummeted and a surge in testing for COVID-19 as well as treatment trials were necessary. The manuscript highlighted all of the changes and the adaptability of the trainees and the faculty to meet the needs of the patients of Houston.”

During the first wave of the pandemic, first author and 2019-20 Chief Resident Paloma Monroig-Bosque, MD, PhD, was the trainee responsible for laboratory management. Her duties included rounding to all laboratories and working as needed in each lab. She began to notice many changes and adaptations in practice that were rapidly occurring because of COVID-19. Dr. Monroig-Bosque stated: “I was very proud to see how the trainees were included in every step of the way. The focus and care for our training was impressive. I sought to try to read what people in pathology were doing regarding involving the trainees in the process and absolutely nothing was published. I thought it would be a good idea to publish the stepwise approach we had used in order to possibly help other programs during this continuing pandemic. It was so much work, but we are so proud of it.”
 
The article is available online now.
Congratulations, all!
Follow us on Twitter!
Enthusiastic PGY1 Residents at Dr. Ro's weekly conference.
The Residency and Fellowship programs of the Department are excited to announce our new Twitter presence! The new account is a collaborative effort between all of the graduate medical education groups at HMH, and will feature regular news and updates from our Pathology residents and fellows.

Follow, like, and retweet us on Twitter @HMethodistGME for updates!
New Faculty
Our Department welcomed Miguelina de la Garza Bravo, MD, as a staff pathologist at HMH. Dr. de la Garza Bravo received her MD in 2010 from the Instituto Tecnologico y de Studios Superiores de Monterrey, where she graduated with honors. Upon graduation from medical school, she moved to Houston and completed a two-year postdoctoral research fellowship at MD Anderson Cancer Center. Dr. de la Garza Bravo then completed a combined Anatomical and Clinical Pathology Residency at HMH in 2016, as well as fellowships in Dermatopathology at Baylor College of Medicine and Ophthalmic Pathology at HMH. She served as Chief Resident (2015-16) and Chief Fellow (2017-18) during her training at HMH. Dr. de la Garza Bravo worked in private practice for two years, including a year as Medical Director of her laboratory. Dr. de la Garza Bravo joined the faculty of HMH in August of this year, and she is very excited to be a part of an outstanding group of pathologists who value each patient and colleague.

Faculty Appointments & Promotions
Andrea Diaz De Vivar, MD, received her faculty appointment as Assistant Professor of Clinical Pathology and Genomic Medicine at the Houston Methodist Academic Institute (HMAI). Dr. Diaz De Vivar joined our Department in March 2019 after having served on the faculty of Baylor College of Medicine and working in private practice. Dr. Diaz De Vivar is the Medical Director of Houston Methodist Baytown Hospital (HMB) and is co-Editor-in-Chief of the Laboratory Report. In addition to her work as Medical Director, Dr. Diaz De Vivar is involved in numerous committees at HMB, and she performs research in the area of gynecologic and obstetric pathology.
Chinnaswamy Jagannath, PhD, received faculty appointments as Professor of Pathology and Genomic Medicine on the Investigation Track at the Houston Methodist Academic Institute (HMAI) and Full Member at the Houston Methodist Research Institute (HMRI). Dr. Jagannath joined our Department in January 2019 as a Senior Scientist in the Center for Molecular and Translational Human Infectious Diseases Research, following over twenty years on the faculty of the University of Texas Health Science Center (UTHSC). With over 40 years’ experience in tuberculosis research, Dr. Jagannath and his laboratory are currently expanding his previous work on the roles that autophagy and mycobacterial genetic modulation play in in vaccine efficacy against Mycobacterium tuberculosis (MTB). His most recent work explores the function of macrophage type in innate immunity and susceptibility to MTB in murine and human models of infection. Dr. Jagannath has served as a reviewer for NIH study sections for over 20 years, and he has appeared in numerous national and international grant review panels over the years.
Arthur Zieske, MD, received his faculty appointment as Associate Professor of Clinical Pathology and Laboratory Medicine at Weill Cornell Medical College (WCMC). Dr. Zieske joined our Department 2011, a role in which he immediately became involved in the educational mission of the Department. Dr. Zieske currently serves as Associate Director of the Hematopathology Section, Medical Director of the Medical Hematology Section, Medical Director of the Hematology and Urinalysis sections of the Core Laboratory, and Director of the Emergency Department laboratories at Cinco Ranch and Cypress Branch. Dr. Zieske holds faculty appointments at the Houston Methodist Academic Institute and Texas A&M Health Science Center, and he has been a recipient in 2018, 2019, and 2020 of HM Graduate Medical Education Exemplary Faculty Teaching Awards.
Weill Cornell Appointments and Promotions
Jian Chen, BM, PhD
Associate Professor of Clinical Pathology and Laboratory Medicine
Ekene Okoye, MD
Associate Professor of Clinical Pathology
and Laboratory Medicine
Randall Olsen, MD, PhD
Professor of Clinical Pathology and Laboratory Medicine
Michael Thrall, MD
Professor of Clinical Pathology and Laboratory Medicine
Congratulations to all of our faculty!
Office of Academic Development News
Meet our New Co-Editors-in-Chief!
The Office of Academic Development (OAD) and Laboratory Report editorial staff are pleased to welcome our newest co-editors in chief to the Laboratory Report team!
Andrea Diaz De Vivar, MD

Dr. Diaz De Vivar joined Houston Methodist Hospital in March 2019 and has been serving as the Laboratory Medical Director at Houston Methodist Baytown Hospital for the last year. Dr Diaz De Vivar joined our group after working at the Texas Children’s Pavilion for Women, CHI St. Luke’s Medical Center, and as an Associate pathologist at Brown and Associates. She received her medical degree in 2001 from the Facultad de Ciencias Medicas (School of Medical Sciences) at the Universidad Nacional de Asuncion (National University of Asuncion) in Paraguay.

After moving to the United States, she completed a combined Anatomic and Clinical Pathology residency at Baylor College of Medicine in 2009, a Cytopathology Fellowship at The University of Texas MD Anderson Cancer Center in 2010, and a Surgical Pathology Fellowship at Houston Methodist in 2011. Her special interest is in Gynecologic and Obstetric Pathology. She was honored with the Robert E. Scully Young Investigator Award in 2014 by the International Society of Gynecological Pathologists for authoring the best printed article in the International Journal of Gynecological Pathology on her introduction of a new classification system for endocervical adenocarcinoma. Dr. Diaz De Vivar has recently been recertified by the ABP in anatomic pathology, clinical pathology and cytopathology.

Dr. Diaz De Vivar has two sons, Martin (17) and Alejandro (13), and is married to Dr. Juan J. Ibarra, who currently serves as an Assistant Professor of Radiology at MD Anderson Cancer Center. She lives in Bellaire, Texas with her family.

Mukul Divatia, MD

Dr. Mukul Divatia received his M.B.B. S. degree with honors from the Maharaja Sayajirao University of Baroda, India in 2002. After completing his pathology residency from the same institution, he undertook a two year fellowship at Tata Memorial Hospital In Mumbai, a sister institute of MD Anderson Cancer Center. Following a brief stint in private practice in his hometown Baroda, he relocated to the United States where he completed a fellowship in Ophthalmic Pathology as well as a residency in Anatomic and Clinical Pathology at the Houston Methodist Hospital, followed by another fellowship in Genitourinary Pathology at Cedars Sinai Medical Center in Los Angeles where he was also the awarded the Sports Spectacular Distinguished Fellow award for his research. Dr. Divatia moved back to Houston thereafter and has been a faculty member with our department since July 2015. He serves on the editorial board of Archives of Pathology and Laboratory Medicine and is a reviewer for several peer reviewed publications in pathology. Dr. Divatia is an ardent teacher and inveterate student of surgical pathology with a special interest in hepatopathology. When he is not signing out cases, he likes to travel and explore novel cuisines and cultures.

Dr. Diaz De Vivar and Dr. Divatia have graciously agreed to serve as co-editors-in-chief and provide oversight and guidance for this and future publications of the Laboratory Report. Many thanks to our previous editor-in-chief, April Ewton, MD, for her years of service in this role!
OAD Participates in First-Ever HMRI-Sponsored
Health Science Practicum
Sasha Pejerrey, PhD, Lead Scientific Writer; Adrienne Winston, Scientific Writer; and Heather McConnell, PhD, Scientific Writer, presented as part of the first-ever virtual Health Science Practicum for students from HISD’s Jones Futures Academy. The practicum was sponsored by the HMRI’s Office of Graduate Studies and Trainee Affairs, and gave students the opportunity to interact firsthand with professionals in a variety of scientific endeavors with the goal of encouraging curiosity and engagement on the part of the students.

OAD members gave an introduction to technical writing, as well as sharing the diverse ways in which they came to become scientific writers for our Department. Students at the Jones Futures Academy fulfill high school graduation requirements while simultaneously earning an Associate’s degree, with an emphasis on technological skills to ready them for the workforce. Dr. Pejerrey, Ms. Winston, and Dr. McConnell are honored to have been a part of this practicum and look forward to more opportunities in the future to share their work with students across Houston.
Dr. Pejerrey and Ms. Winston ready for the virtual presentation.
The Office of Academic Development (OAD) of the Department of Pathology and Genomic Medicine is available and fully staffed during the current SARS-CoV-2 pandemic to assist department members with editing manuscripts, grants, posters, presentations, and more. Please contact Sasha Pejerrey at spejerrey@houstonmethodist.org or 713.441.5889; Adrienne Winston at awinston@houstonmethodist.org or 713.441.3395; or Heather McConnell at hmcconnell@houstonmethodist.org 0r 346.238.4346. There is no charge for the OAD’s services, and no project is too big or too small!
 
If you need help reducing percent overlap within a document for a specific journal requirement, please let us know! We have access to iThenticate and expertise in reducing overlap to whatever percent a particular journal may require.

Faculty Publications
Long SW, Olsen RJ, Christensen PA, Bernard DW, Davis JJ, Shukla M, Nguyen M, Saavedra MO, Yerramilli P, Pruitt L, Subedi S, Kuo HC, Hendrickson H, Eskandari G, Nguyen HAT, Long JH, Kumaraswami M, Goike J, Boutz D, Gollihar J, McLellan JS, Chou CW, Javanmardi K, Finkelstein IJ, Musser JM. Molecular Architecture of Early Dissemination and Massive Second Wave of the SARS-CoV-2 Virus in a Major Metropolitan Area. mBio. 2020 Oct 30;11(6):e02707-20. https://doi.org/10.1128/mBio.02707-20

Wu L, Xia M, Sun X, Han X, Zu Y, Jabbour EJ, et al. High levels of immunoglobulin expression predict shorter overall survival in patients with acute myeloid leukemia. European Journal of Haematology. 2020 Oct 1;105(4):449-459. https://doi.org/10.1111/ejh.13466
 
Cathcart SJ, Greene EP, Powell SZ, Arumanayagam AS, Rivera AL, Tawil R, Appel SH, Cykowski MD. Spinal Cord and Motor Neuron TDP-43 Pathology in a Sporadic Inclusion Body Myositis Patient. Journal of Neuropathology and Experimental Neurology. 2020 Oct 1;79(10):1130-1133. https://doi.org/10.1093/jnen/nlaa066
 
Zhu L, Yerramilli P, Pruitt L, Saavedra MO, Cantu CC, Olsen RJ, Beres SB, Waller AS, Musser JM. Genome-wide assessment of streptococcus agalactiae genes required for survival in human whole blood and plasma. Infection and Immunity. 2020 Oct;88(10). e00357. https://doi.org/10.1128/IAI.00357-20
 
Zhan Y, Debs D, Khan MA, Nguyen DT, Graviss EA, Khalaf S, et al. Natural History of Functional Tricuspid Regurgitation Quantified by Cardiovascular Magnetic Resonance. Journal of the American College of Cardiology. 2020 Sep 15;76(11):1291-1301. https://doi.org/10.1016/j.jacc.2020.07.036
 
Salazar E, Kuchipudi SV, Christensen PA, Eagar T, Yi X, Zhao P, Jin Z, Long SW, Olsen RJ, Chen J, Castillo B, Leveque C, Towers D, Lavinder JJ, Gollihar J, Cardona JA, Ippolito GC, Nissly RH, Bird I, Greenawalt D, Rossi RM, Gontu A, Srinivasan S, Poojary I, Cattadori IM, Hudson P, Josleyn NM, Prugar L, Huie KE, Herbert AS, Bernard DW, Dye JM, Kapur V, Musser JM. Convalescent plasma anti-SARS-CoV-2 spike protein ectodomain and receptor binding domain IgG correlate with virus neutralization. The Journal of Clinical Investigation. 2020 Sep 10. https://doi.org/10.1172/JCI141206
 
Jakowenko N, Nguyen S, Ruegger M, Dinh A, Salazar E, Donahue KR. Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health system. Thrombosis Research. 2020 Dec;196:276-282. https://doi.org/10.1016/j.thromres.2020.09.002
 
Hong BYB, Bean A, Vickers A, Cykowski M, Lee AG. Fourth Nerve Palsy Due to Neurocysticercosis. Journal of Neuro-Ophthalmology: The Official Journal of the North American Neuro-Ophthalmology Society. 2020 Sep 1;40(3):414-416. https://doi.org/10.1097/WNO.0000000000000785
Thrall MJ, Vrbin C, Barkan GA, Monaco SE, Pambuccian SE, Pantanowitz L, et al. Small core needle biopsies in cytology practice: a survey of members of the American Society of Cytopathology. Journal of the American Society of Cytopathology. 2020 Sep 1;9(5):310-321. https://doi.org/10.1016/j.jasc.2020.06.002

Anand K, Phung TL, Bernicker EH, Cagle PT, Olsen RJ, Thomas JS. Clinical Utility of Reflex Ordered Testing for Molecular Biomarkers in Lung Adenocarcinoma. Clinical Lung Cancer. 2020 Sep;21(5):437-442. https://doi.org/10.1016/j.cllc.2020.05.007

Warmke L, Vining D, Ward J, Lin M, Ro JY, Zhang M. Paratesticular clear cell carcinoma of müllerian origin—A case report. Human Pathology: Case Reports. 2020 Sep;21. 200401. https://doi.org/10.1016/j.ehpc.2020.200401

Southon SB, Beres SB, Kachroo P, Saavedra MO, Erlendsdóttir H, Haraldsson G, Yerramilli P, Pruitt L, Zhu L, Musser JM, Kristinsson KG. Population genomic molecular epidemiological study of macrolide-resistant streptococcus pyogenes in Iceland, 1995 to 2016: Identification of a large clonal population with a pbp2x mutation conferring reduced in vitro β-Lactam Susceptibility. Journal of Clinical Microbiology. 2020 Sep;58(9). e00638-20. https://doi.org/10.1128/JCM.00638-20

Li M, Liu W, Bauch T, Graviss EA, Arduino RC, Kimata JT et al. Clearance of HIV infection by selective elimination of host cells capable of producing HIV. Nature Communications. 2020 Aug 13;11(1). 4051. https://doi.org/10.1038/s41467-020-17753-w

Stroup BM, Marom R, Li X, Hsu CW, Chang CY, Truong LD, et al. A global Slc7a7 knockout mouse model demonstrates characteristic phenotypes of human lysinuric protein intolerance. Human Molecular Genetics. 2020 Aug 3;29(13):2171-2184. https://doi.org/10.1093/hmg/ddaa107

Olsen RJ, Zhu L, Musser JM. A Single Amino Acid Replacement in Penicillin-Binding Protein 2X in Streptococcus pyogenes Significantly Increases Fitness on Subtherapeutic Benzylpenicillin Treatment in a Mouse Model of Necrotizing Myositis. American Journal of Pathology. 2020 Aug 1;190(8):1625-1631. https://doi.org/10.1016/j.ajpath.2020.04.014

Xu L, Polski A, Prabakar RK, Reid MW, Chevez-Barrios P, Jubran R, et al. Chromosome 6p Amplification in Aqueous Humor Cell-Free DNA Is a Prognostic Biomarker for Retinoblastoma Ocular Survival. Molecular Cancer Research. 2020 Aug 1;18(8):1166-1175. https://doi.org/10.1158/1541-7786.MCR-19-1262

Lunsford KE, Agopian VG, Yi S, Nguyen DT, Graviss EA, Harlander-Locke MP, et al. Delayed Implantation of Pumped Kidneys Decreases Renal Allograft Futility in Combined Liver-Kidney Transplantation. Transplantation. 2020 Aug 1;1591-1603. https://doi.org/10.1097/TP.0000000000003040

Arora K, El-Zaatari ZM, Schwartz MR, Ro J. Lesions of anogenital mammary-like glands: Four cases including novel pathologic and immunohistochemical observations. Annals of Diagnostic Pathology. 2020 Aug 1;47. 151551. https://doi.org/10.1016/j.anndiagpath.2020.151551

Shields C, Kim M, Lally S, Chévez-Barrios P, Shields J. Eye cancer in a young male with a vaping history. Indian Journal of Ophthalmology. 2020 Aug;68(8):1699-1701. https://doi.org/10.4103/ijo.IJO_27_20

Xia R, Varnado S, Graviss EA, Nguyen DT, Cruz-Solbes A, Guha A, et al. Role of thromboelastography in predicting and defining pump thrombosis in left ventricular assist device patients. Thrombosis Research. 2020 Aug;192:29-35. https://doi.org/10.1016/j.thromres.2020.03.016
Salazar E, Perez KK, Ashraf M, Chen J, Castillo B, Christensen PA, Eubank T, Bernard DW, Eagar TN, Long SW, Subedi S, Olsen RJ, Leveque C, Schwartz MR, Dey M, Chavez-East C, Rogers J, Shehabeldin A, Joseph D, Williams G, Thomas K, Masud F, Talley C, Dlouhy KG, Lopez BV, Hampton C, Lavinder J, Gollihar JD, Maranhao AC, Ippolito GC, Saavedra MO, Cantu CC, Yerramilli P, Pruitt L, Musser JM. Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma. American Journal of Pathology. 2020 Aug;190(8):1680-1690. https://doi.org/10.1016/j.ajpath.2020.05.014

Xu-Monette ZY, Zhang H, Zhu F, Tzankov A, Bhagat G, Visco C, Dybaker K, Chiu A, Tam W, Zu Y, Hsi ED, You H, Huh J, Pnzoni M, Ferreri AJM, Moller MB, Parsons BM, vn Krieken JH, Piris MA, Winter JN, Hagemeister FB, Shahbaba B, De Dios I, Zhang H, Li Y, Xu B, Albitar M, Young KH. A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL. Blood Advances. 2020 Jul 28;4(14):3391-3404. https://doi.org/10.1182/bloodadvances.2020001949

Mishra A, Singh VK, Actor JK, Hunter RL, Jagannath C, Subbian S, Khan A. GM-CSF Dependent Differential Control of Mycobacterium tuberculosis Infection in Human and Mouse Macrophages: Is Macrophage Source of GM-CSF Critical to Tuberculosis Immunity? Frontiers in Immunology. 2020 Jul 23;11. 1599. https://doi.org/10.3389/fimmu.2020.01599

Makthal N, Do H, Wendel BM, Olsen RJ, Helmann JD, Musser JM, Kumaraswami M. Group A Streptococcus AdcR Regulon Participates in Bacterial Defense against Host-Mediated Zinc Sequestration and Contributes to Virulence. Infection and Immunity. 2020 Jul 21;88(8). https://doi.org/10.1128/IAI.00097-20

Eubank TA, Long SW, Perez KK. Role of Rapid Diagnostics in Diagnosis and Management of Patients With Sepsis. The Journal of Infectious Diseases. 2020 Jul 21;222(Supplement_2):S103-S109. https://doi.org/10.1093/infdis/jiaa263

Manouchehri N, Hussain RZ, Cravens PD, Doelger R, Greenberg BM, Okuda DT, Forsthuber TG, Eagar TN, Stuve O. Limitations of cell-lineage-specific non-dynamic gene recombination in CD11c.Cre+ITGA4fl/fl mice. Journal of Neuroimmunology. 2020 Jul 15;344. 577245. https://doi.org/10.1016/j.jneuroim.2020.577245

Nwokedi U, Nguyen DT, Meisenbach LM, Chihara R, Chan EY, Graviss EA, et al. Short-term outcome of routine use of EndoFLIP during hiatal hernia repair. Surgical Endoscopy. 2020 Jul 14. https://doi.org/10.1007/s00464-020-07788-x

Bishop-Freeman SC, Bertholf RL, Powers RH, Mayhew LC, Winecker RE. False-Positive Enzymatic Alcohol Results in Perimortem Specimens. Laboratory Medicine. 2020 Jul 8;51(4):394-401. https://doi.org/10.1093/labmed/lmz082

Khan MA, Yang EY, Nguyen DT, Nabi F, Hinojosa J, Jabel M, Nagueh SF, Graviss EA, Shah DJ. Examining the Relationship and Prognostic Implication of Diabetic Status and Extracellular Matrix Expansion by Cardiac Magnetic Resonance. Circulation: Cardiovascular Imaging. 2020 Jul 1;13(7). e011000. https://doi.org/10.1161/CIRCIMAGING.120.011000

Suo L, Liu S, Vega I, Thrall M. Extramedullary multiple myeloma involving the liver and periportal lymph node, diagnosed by EUS-FNA in a patient with cirrhosis. Diagnostic Cytopathology. 2020 Jul 1;48(7):657-661. https://doi.org/10.1002/dc.24416

Soliman BG, Nguyen DT, Chan EY, Chihara RK, Meisenbach LM, Graviss EA et al. Impact of da Vinci Xi robot in pulmonary resection. Journal of Thoracic Disease. 2020 Jul 1;12(7):3561-3572. https://doi.org/10.21037/jtd-20-720

Vahidy FS, Bernard DW, Boom ML, Drews AL, Christensen P, Finkelstein J, et al. Prevalence of SARS-CoV-2 Infection Among Asymptomatic Health Care Workers in the Greater Houston, Texas, Area. JAMA Network Open. 2020 Jul 1;3(7):e2016451. https://doi.org/10.1001/jamanetworkopen.2020.16451

Ali AB, Khan NA, Nguyen DT, Chihara R, Chan EY, Graviss EA, et al. Robotic and per-oral endoscopic myotomy have fewer technical complications compared to laparoscopic Heller myotomy. Surgical Endoscopy. 2020 Jul 1;34(7):3191-3196. https://doi.org/10.1007/s00464-019-07093-2

Iso T, Rizk E, Harris JE, Salazar E, Heyne K, Herrera E, et al. Viable Hemostasis Obtained With Prothrombin Complex Concentrate in Patients Who Refuse Standard Allogeneic Blood Transfusion and Undergo Complex Cardiac Surgery: A Case Series. A&A Practice. 2020 Jul 1;14(9):e01276. https://doi.org/10.1213/XAA.0000000000001276
Long SW, Saavedra MO, Christensen PA, Musser JM, Olsen RJ. Human Infections Caused by Clonally Related African Clade (Clade III) Strains of Candida auris in the Greater Houston Region. Journal of Clinical Microbiology. 2020 Jul;58(7). e02063-19. https://doi.org/10.1128/JCM.02063-19

Robbins RJ, Thomas JS, Osuna PM, Shakil J. A BRAF V600E Mutation in RET-Negative Medullary Thyroid Cancer. Case Reports in Endocrinology. 2020;2020. 7641940. https://doi.org/10.1155/2020/7641940

Lin MS, Ngo T, Schwartz MR, Mehta RR, Ayala AG, Ro JY. Anastomosing hemangioma of the breast: An unusual case at an unusual site. Journal of Breast Cancer. 2020;23(3):326-330. https://doi.org/10.4048/jbc.2020.23.e15

Szymanski TW, Weeks PA, Lee Y, Kumar S, Castillo B, Kar B, et al. Anticoagulation of impella with a bivalirudin purge solution. ASAIO Journal. 2020;E117-E120. https://doi.org/10.1097/MAT.0000000000001126
Suo L, Vega I, Thrall M. Cyto-histo correlations of plasmacytoid and micropapillary variants of high-grade urothelial carcinoma: do they fit well in The Paris System for reporting urinary cytology? Journal of the American Society of Cytopathology. 2020. https://doi.org/10.1016/j.jasc.2020.05.013

Lee J, Yoo Y, Park S, Cho MS, Sung SH, Ro JY. Double cocktail immunostains with high molecular weight cytokeratin and GATA-3: Useful stain to discriminate in situ involvement of prostatic ducts or acini from stromal invasion by urothelial carcinoma in the prostate. Journal of Pathology and Translational Medicine. 2020;54(2):146-153. https://doi.org/10.4132/jptm.2019.11.12

Timmons CF, Black-Schaffer WS, Naritoku WY, Powell SZ, Johnson KA, Brissette MD, et al. Entry of Graduates of US Pathology Residency Programs Into the Workforce: Cohort Data Between 2008 and 2016 Remain Positive and Stable. Academic Pathology. 2020;7. https://doi.org/10.1177/2374289520901833

Messer JA, Zuhour RJ, Haque W, Lewis GD, Schefler AC, Wong A, Bernicker EH, Chévez-Barrios P, Quan EH, Farach A, Butler EB, Teh BS. Eye plaque brachytherapy versus enucleation for ocular melanoma: an analysis from the National Cancer Database. Journal of Contemporary Brachytherapy. 2020;12(4):303-310. https://doi.org/10.5114/jcb.2020.98108

Eraso JM, Kachroo P, Olsen RJ, Beres SB, Zhu L, Badu T, Shannon S, Cantu CC, Saavedra MO, Kubiak SL, Porter AR, DeLeo FR, Musser JM. Genetic heterogeneity of the Spy1336/R28—Spy1337 virulence axis in Streptococcus pyogenes and effect on gene transcript levels and pathogenesis. PLoS ONE. 2020;15(3). e0229064. https://doi.org/10.1371/journal.pone.0229064

Ahmed A, Granillo A, Burns E, Glassner K, Naseem N, Force C, Crumley SM, Drew A. Herpes Simplex Virus-2 Hepatitis: A Case Report and Review of the Literature. Case Reports in Medicine. 2020;2020. 8613840. https://doi.org/10.1155/2020/8613840

Dickinson KJ, Bass BL, Graviss EA, Nguyen DT, Pei KY. How learning preferences and teaching styles influence effectiveness of surgical educators. American Journal of Surgery. 2020. https://doi.org/10.1016/j.amjsurg.2020.08.028

Mindikoglu AL, Coarfa C, Opekun AR, Shah VH, Arab JP, Lazaridis KN, Putluri N, Ambati CR, Robertson MJ, Devaraj S, Jalal PK, Rana A, Goss JA, Dowling TC, Weir MR, Seliger SL, Raufman JP, Bernard DW, Vierling JM. Metabolomic biomarkers are associated with mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis. Future Science OA. 2020;6(2). https://doi.org/10.2144/fsoa-2019-0124
Monroig-Bosque PDC, Hsu JW, Lin MS, Shehabeldin AN, Rogers JT, Kim CF, Kalsekar AG, Jin Z, Cara LR, Barbieri AN, El-Zaatari Z, Eskandari G, Sheu TG, Tomsula JA, Long SW, Zieske AW, Leveque CM, Salazar E, Mody DR, Schwartz MR, Cykowski MD, Yi X, Powell SZ, Thomas JS. Pathology Trainee Redeployment and Education During the COVID-19 Pandemic: An Institutional Experience. Academic Pathology. 2020;7. https://doi.org/10.1177/2374289520953548

Karanth S, Nelson PT, Katsumata Y, Kryscio RJ, Schmitt FA, Fardo DW, Cykowski MD, Jicha GA, Van Eldik LJ, Abner EL. Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults. JAMA Neurology. 2020. https://doi.org/10.1001/jamaneurol.2020.1741

Musser JM, Beres SB, Zhu L, Olsen RJ, Vuopio J, Hyyryläinen HL, et al. Reduced in vitro susceptibility of Streptococcus pyogenes to β-lactam antibiotics associated with mutations in the pbp2x gene is geographically widespread. Journal of Clinical Microbiology. 2020;58(4). e01993-19. https://doi.org/10.1128/JCM.01993-19

Hao S, Lu X, Gong Z, Bassett RL, Hu S, Konoplev SN et al. The survival impact of CKS1B gains or amplification is dependent on the background karyotype and TP53 deletion status in patients with myeloma. Modern Pathology. 2020. https://doi.org/10.1038/s41379-020-00669-7

Choi JH, Ro JY. Retroperitoneal Sarcomas: An Update on the Diagnostic Pathology Approach. Diagnostics. 2020 Sep;10(9). 642. https://doi.org/10.3390/diagnostics10090642

Kim DK, Kim JW, Ro JY, Lee HS, Park JY, Ahn HK, et al. Plasmacytoid variant urothelial carcinoma of the bladder: A systematic review and meta-analysis of clinicopathological features and survival outcomes. Journal of Urology. 2020 Aug 1;204(2):215-223. https://doi.org/10.1097/JU.0000000000000794

Samaratunga H, Delahunt B, Srigley JR, Berney DM, Cheng L, Evans A, Furusato B, Leite KRM, MacLennan GT, Martignoni G, Moch H, Pan CC, Paner G, Ro J, Thunders M, Tsuzuki T, Wheeler T, van der Kwast T, Varma M, Williamson SR, Yaxley JW, Egevad L. Granular necrosis: a distinctive form of cell death in malignant tumours. Pathology. 2020 Aug;52(5):507-514. https://doi.org/10.1016/j.pathol.2020.06.002

THE LABORATORY REPORT is a publication of the Houston Methodist Department of Pathology and Genomic Medicine
Editors-in-Chief
Andrea Diaz De Vivar, MD
Mukul Divatia, MD

Editorial Committee
Hazel Awalt, MD
Byron Moore, MD
Seema Mullick, MD
Thu Ngo, MD
Steven Shen, MD, PhD
Editorial Coordinators
Sasha M. Pejerrey, PhD
Adrienne Winston
Heather McConnell, PhD

Department Chair
James M. Musser, MD, PhD

Houston Methodist Hospital
Mark Vassallo, MSN, RN
Manual Hinojosa, MHA
James Cook, MBA, MT(AS-CP) DLM